Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.682
+0.037 (2.25%)
Jul 3, 2026, 5:29 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 664.87 million as of July 2, 2026. Its market cap has increased by 103.67% in one year.
Market Cap
664.87M
Enterprise Value
598.52M
Revenue
83.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.68
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 664.87M, a decrease of -60.18%. That is a compound annual growth rate of -9.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 664.87M | -49.26% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.07B |
| SynAct Pharma AB | 1.05B |
| Infant Bacterial Therapeutics AB | 941.65M |
| Xspray Pharma AB | 723.58M |
| AlzeCure Pharma AB | 712.47M |
| FluoGuide | 622.91M |
| Cantargia AB | 523.08M |
| Corline Biomedical AB | 482.16M |